학술논문
Blinatumomab Alternating With Low-Intensity Chemotherapy (CT) Treatment for Older Adults With Newly Diagnosed Philadelphia (Ph)-Negative B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) is Well Tolerated and Efficacious: Safety Run-In Results for the Phase 3 Randomized Controlled Golden Gate Study
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:6134-6136
Subject
Language
ISSN
0006-4971